Pleased to announce our participation in the 24th EURETINA Congress!
Cristina Andrés, our Medical Device Area Director, will be speaking at the symposium “Emulsification of Silicone Oil: New Advances”
📅 Friday, September 20, at 15:15 CEST
📍 Room 113 / 114
#EURETINA24
Nuestras compañeras del @IobaUVa, Cristina Andrés Iglesias y Rosa M. Coco Martín, participan en el importante #Congreso#Euretina2024 que se desarrollará tanto presencialmente en Barcelona como online del 19 al 22 de septiembre.
ℹ️ Más info: https://t.co/zYYFtOIm9W
#EquipoIOBA
🔬💡 Discover CELab! 🌟 The Controlled Environment Laboratory (CELab) at VISION R&D, with its exposure and evaluation chambers, offers cutting-edge technology for high-quality research and clinical trials. #research#Eyecare
👁💡💉 Discover cutting-edge solutions in Ophthalmology with Vision R&D! 💪 Specializing in preclinical and clinical projects, as well as evaluation of ocular medical devices. 👁🌍Contact us today! 📞 #VisionRD#OcularHealth#MedicalInnovation
💡💻 Nuestros servicios incluyen consultoría en investigación y desarrollo, pruebas clínicas, gestión de proyectos y análisis de datos. Trabajamos de cerca con nuestros clientes para garantizar que sus objetivos se cumplan de manera eficiente y efectiva.
#InnovaciónEnOftalmología
Welcome Laura Sánchez García! 😊 She is a student of Higher Level Training Cycle in Pathological Anatomy and Cytodiagnostics 🔬 (Ramón y Cajal high school). She will be with us for the next few months doing his internship! 👁️🙌
#visionrd#uva
🔎🔎We are looking for candidates to apply for a PhD thesis under the Industrial Doctorate program of the Ministry of Science and Innovation
👉 https://t.co/B33kWWhvW6.
On Wednesday, February 1st, the next IOBA UVa research webinar will take place. Marta Blanco Vázquez( Vision R&D) will talk about "Potential biomarkers for chronic ocular pain associated with dry eye disease". This project has been conducted in the #CELab.
#research#dryeye
Moreover, the benefits of the therapy are sustained for at least one-year post-treatment
Open access: https://t.co/OpdmLdbpxM
Congratulations to all the authors!👏
#Ophthalmology#research#Medicaldevices
The Ocular Surface Group of the IOBA UVa has recently published a prospective study conducted at the Controlled Environment Laboratory (CELab)
@IobaUVa
The results reveal that a single session of LipiFlow treatment can improve objective and subjective outcomes of the lacrimal functional unit in Meibomian gland dysfunction patients assessed under controlled environmental conditions 👁️ 🔍
Are you looking for experimental models of ocular diseases? 👁️
IOBA and VISION R&D offer experimental models of ocular diseases to the industry or scientific groups. These models are supported by scientific publications and years of experience. @IobaUVa#Ophthalmology
@MedicalMix is an excellent Spanish company with which we have been collaborating for years. And especially with its drug division, @Farmamix Vision in the development of a possible topical drug to curb diabetic retinopathy
#diabeticretinopathy#diabetes#Ophthalmology